Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Completed 30Unknown 5Terminated 5Recruiting 3Suspended 2Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Specimen Handling 31Magnetic Resonance Spectroscopy 19Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Surgical Procedures, Operative 5Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Oxycodone × Clear all
NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Suspended
100 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended
320 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡